MedPath

Study on the treatment of ulcerative colitis in mild to moderate active stage by removing dampness

Phase 1
Recruiting
Conditions
lcerative colitis
Registration Number
ITMCTR2000003426
Lead Sponsor
Guangdong Provincial Hospital of Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Cases that meet the diagnostic criteria of Western medicine, clinical diagnosis and TCM dampness syndrome diagnosis;
2. Patients who meet the criteria of ulcerative colitis in mild and moderate active stage;
3. Patients who sign informed consent and have good compliance can be followed up;
4. Outpatients or inpatients aged between 18 and 70 years;
5. Patients who do not use drugs or other treatments that affect the efficacy evaluation during the treatment.

Exclusion Criteria

1. Chronic schistosomiasis, bacillary dysentery, intestinal tuberculosis and other infectious colitis and colon Crohn's disease, radiation enteritis and ischemic enteritis;
2. Lactation, pregnant women and patients who are intolerant to the drug;
3. Patients with serious primary diseases such as heart, lung, liver, kidney and hematopoietic system, and psychosis;
4. Patients with serious complications such as local stenosis, toxic megacolon, intestinal obstruction, colon cancer, rectal cancer, intestinal perforation and anal disease;
5. Disabled patients (dumb, deaf, blind, mental disorder, physical disability, mental disorder) as prescribed by law.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.